Statements have not been evaluated by the FDA or any regulatory authority
Indeed, BPC 157 use has not been approved by the US Food and Drug Administration, meaning that it cannot legally be prescribed or purchased in the USA
For the cyanocobalamin component, while generally considered safe with few absolute contraindications, certain conditions warrant caution
2014 May 5;6(5):1861-73
These two systems are inseparable, because the dose changes every four weeks and each change means a different number of syringe units
Molecular pathways documented in preclinical research include: (1) activation of nitric oxide (NO) synthesis via L-arginine/eNOS pathway, (2) transcriptional upregulation of VEGF-A and FGF-2 favouring angiogenesis, (3) modulation of the Egr-1 early transcription factor involved in fibroblast proliferation, (4) interaction with 5-HT2A and dopaminergic receptors in some behavioural models, (5) stabilisation of endothelial function via eNOS modulation and reduction of oxidative stress (8-OH-dG, MDA)